Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Study identifies causes of cancer
A team of Yale-led researchers in the USA can now quantify the factors causing changes…
Artificial intelligence helps physicians better assess the effectiveness of bladder cancer treatment
In a small but multi-institutional study, an artificial intelligence-based system improved providers’ assessments of whether patients…
Genomic sequencing is changing diagnosis and treatment for patients with brain cancer
Patients diagnosed with a type of brain tumour survived for longer when they were treated…
Young cancer survivors at greater risk of mental health disorders
Young cancer survivors are at greater risk of poor mental health, a new UNSW study shows. The research could help…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.